Slide 1Ovarian Stimulation in IUI- Overview Dr. Jyoti Bhaskar MD MRCOG Director Lifecare IVF Slide 2 # Rationale for COH in IUI Increasing the number of eggs available for…
1. Fertility preservation, from cancer to benign disease to social reasons: the challenge of the present decade Jacques Donnez, M.D., Ph.D. Infertility Research Unit, Socie…
Luteal phase support in ART Aboubakr Elnashar Benha university Hospital, Egypt Aboubakr Elnashar CONTENTS 1. WHY? 2. INDICATIONS 3. WHEN TO START? 4. WHEN TO STOP? 5. WHAT…
1. l/ Iotherhooci / -. f'i: e r M e n o p/ -_u seFind out how new technology is pushing the limits of fertility so that age is no longer a barrier to bearing a child…
Slide 1 Luveris ® New Drug Application (21-322 ) Kate Meaker, M.S. Statistical Reviewer Division of Biometrics II Kate Meaker, M.S. Statistical Reviewer Division of Biometrics…
Georg Griesinger UK-SH, Campus Luebeck Germany OHSS death of a 31-year-old woman …who developed a fatal adult respiratory distress syndrome Fineschi et al., 2006 autopsy…
IUI 2011 Prof. Dr. Esat ORHON * Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI)…